Promoting Disassembly News Today

This article will discuss the potential of graphene oxide in a range of therapeutic procedures, particularly those surrounding neurodegenerative conditions such as Alzheimer’s.

Graphene oxide affects the metabolism of the cells, in a way that increases their resistance to misfolded proteins and oxidative stress.

<p>A probable early driver of Alzheimer's disease is the accumulation of molecules called amyloid peptides. These cause cell death, and are commonly found in the brains of Alzheimer’s patients. Researchers at Chalmers University of Technology, Sweden, have now shown that yeast cells that accumulate these misfolded amyloid peptides can recover after being treated with graphene oxide nanoflakes.</p>